| 000 | 01849 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516092300.0 | ||
| 264 | 0 | _c20121015 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1745-7254 | ||
| 024 | 7 |
_a10.1038/aps.2012.34 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPunfa, Wanisa | |
| 245 | 0 | 0 |
_aEnhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells. _h[electronic resource] |
| 260 |
_bActa pharmacologica Sinica _cJun 2012 |
||
| 300 |
_a823-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies _xchemistry |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCervix Uteri _xdrug effects |
| 650 | 0 | 4 |
_aCurcumin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLactic Acid _xchemistry |
| 650 | 0 | 4 |
_aNanoparticles _xchemistry |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 |
_aPoloxamer _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPolyglycolic Acid _xchemistry |
| 650 | 0 | 4 | _aPolylactic Acid-Polyglycolic Acid Copolymer |
| 650 | 0 | 4 |
_aUterine Cervical Neoplasms _xdrug therapy |
| 700 | 1 | _aYodkeeree, Supachai | |
| 700 | 1 | _aPitchakarn, Pornsiri | |
| 700 | 1 | _aAmpasavate, Chadarat | |
| 700 | 1 | _aLimtrakul, Pornngarm | |
| 773 | 0 |
_tActa pharmacologica Sinica _gvol. 33 _gno. 6 _gp. 823-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/aps.2012.34 _zAvailable from publisher's website |
| 999 |
_c21776472 _d21776472 |
||